Table 2.
Variable | NXAS (n = 30) | Zopiclone (n = 30) | Placebo (n = 30) |
---|---|---|---|
Rehabilitation, n | 2 | 1 | 0 |
Markedly effective, n | 10 | 11 | 0 |
Effective, n | 11 | 12 | 9 |
Invalid, n | 7 | 6 | 21 |
Effectiveness (%) | 76.67 | 80.00 | 30.00 |
P-value | <0.01 |
Variable | NXAS (n = 30) | Zopiclone (n = 30) | Placebo (n = 30) |
---|---|---|---|
Rehabilitation, n | 2 | 1 | 0 |
Markedly effective, n | 10 | 11 | 0 |
Effective, n | 11 | 12 | 9 |
Invalid, n | 7 | 6 | 21 |
Effectiveness (%) | 76.67 | 80.00 | 30.00 |
P-value | <0.01 |